Zomedica Pharmaceuticals Corp. focuses on animal diagnostics and therapies in the companion animal industry with an emphasis on developing solutions for previously unmet needs.

Creating a diverse portfolio of diagnostics and therapeutics in the $10B companion animal market.

 INITIATION REPORT

NYSE American: ZOM

Initiates coverage on:

Zomedica 

Zomedica Pharmaceuticals is a client of PCG Advisory, Inc., an investor relations and communications firm. Please see our disclosures in the research report as well as on our website www.pcgadvisory.com

Download the exclusive report and learn more about: